Great bioMérieux Lunch Symposium at ECCMID 2022. What I learned is that fast is good but timely is even better. 2 learnings from our practical examples. From Gian Maria Rossollini - BSI management needs to combine genotypic information coming from BIOFIRE for instance and phenotypic information, fast AST, coming from SPECIFIC REVEAL. From Vanya Gant from UK & Netherlands clinical trials that need to move away from tradition gold standards being microbiology to breakthrough technologies with BIOFIRE FILMARRAY Pneumonia Panel which for him are the next gold standard for pneumonia diagnosis.... More watch the interview of Dr Sébastien Spinali - VP for Medical Affairs for EME Region

свернуть